|国家科技期刊平台
首页|期刊导航|临床肝胆病杂志|转移性肝癌的治疗现状与展望

转移性肝癌的治疗现状与展望OA北大核心CSTPCD

Treatment of metastatic liver cancer:Current status and future perspectives

中文摘要英文摘要

肝脏是恶性肿瘤最常见的转移部位之一,肝转移也是转移性肿瘤的主要致死原因.转移性肝癌具有高度异质性,长期以来临床治疗进展缓慢.近年来,随着外科技术的提高、系统治疗的进步及多学科团队诊疗模式的开展,转移性肝癌的临床治疗发生了革命性的变化.本文从外科治疗、系统治疗及局部区域治疗三个方面回顾了近年来转移性肝癌临床治疗进展.以化疗、靶向与免疫治疗为基础的联合疗法仍是转移性肝癌综合治疗的基础,而外科治疗的价值也在部分寡转移患者中得到证实.另外,局部区域治疗的发展为转移性肝癌患者带来新的治疗选择.基于高级别循证医学证据及相关指南的规范化诊疗,及多学科团队指导下的个体化精准治疗,将是未来转移性肝癌临床治疗的发展方向.

The liver is a common metastatic site of malignant tumors,and liver metastasis is also the leading cause of death due to metastatic tumors.Metastatic liver cancer has high heterogeneity,and there has been slow progress in the treatment of metastatic liver cancer for a long time.In recent years,the development of surgical techniques,systemic therapy,and the multidisciplinary team(MDT)diagnostic and therapeutic mode has led to revolutionary changes in the clinical management of metastatic liver cancer.The article reviews the recent progress in the treatment of metastatic liver cancer from the three aspects of surgical treatment,systemic therapy,and locoregional therapy.Combined therapy based on chemotherapy,targeted therapy,and immunotherapy remains the basic multimodality therapy for metastatic liver cancer.In addition,the development of locoregional therapy has brought new treatment options for patients with metastatic liver cancer.Standardized diagnosis and treatment based on high-level evidence-based evidence and related guidelines and individualized precise treatment under the guidance of MDT will be the future directions for the clinical management of metastatic liver cancer.

王祥宇;陈进宏

复旦大学附属华山医院普外科肝胆外科中心,上海 200040

肿瘤转移治疗学

Neoplasm MetastasisLiverTherapeutics

《临床肝胆病杂志》 2024 (007)

1289-1294 / 6

上海市"科技创新行动计划"优秀学术带头人计划项目(22XD1400300) Excellent Academic Leader Project of Shanghai"Science and Technology Innovation Action Plan"(22XD1400300)

10.12449/JCH240701

评论